Comparision of the cytotoxic effects of birch bark extract, betulin and betulinic acid towards human gastric carcinoma and pancreatic carcinoma drug-sensitive and drug-resistant cell lines

Molecules

Volumn 14, Issue 4, 2009, Pages 1639-1651

  Drag, Marcin ^a   Surowiak, Pawel ^b,c,d   Malgorzata, Drag Zalesinska ^b   Dietel, Manfred ^c   Lage, Hermann ^c   Oleksyszyn, Józef ^a  

^a WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c Charité Campus Benjamin Franklin Medical Center   (Germany)

^d Dolnoslaskie Centrum Onkologii Wroclaw   (Poland)

Author keywords

Betulin; Betulinic acid; Birch; Gastric carcinoma; Pancreatic carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; BETULIC ACID; BETULIN; PLANT EXTRACT; TRITERPENE;

ARTICLE; BARK; BIRCH; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; DRUG RESISTANCE; HUMAN; PANCREAS TUMOR; STOMACH TUMOR; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BETULA; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; HUMANS; MOLECULAR STRUCTURE; PANCREATIC NEOPLASMS; PLANT BARK; PLANT EXTRACTS; STOMACH NEOPLASMS; TRITERPENES;

EID: 66349104551     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules14041639     Document Type: Article

References (30)

1. Siddik, Z.H. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 2003, 22, 7265-7279.
2. Lage, H. ABC-transporters: implications on drug resistance from microorganisms to human cancers. Int. J. Antimicrob. Agents 2003, 22, 188-199.
3. Materna, V.; Stege, A.; Surowiak, P.; Priebsch, A.; Lage, H. RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells. Biochem. Biophys. Res. Commun. 2006, 348, 153-157.
4. Kowalski, P.; Surowiak, P.; Lage, H. Reversal of different drug-resistant phenotypes by an autocatalytic multitarget multiribozyme directed against the transcripts of the ABC transporters MDR1/P-gp, MRP2, and BCRP. Mol. Ther. 2005, 11, 508-522.
5. Mantwill, K.; Kohler-Vargas, N.; Bernshausen, A.; Bieler, A.; Lage, H.; Kaszubiak, A.; Surowiak, P.; Dravits, T.; Treiber, U.; Hartung, R.; Gansbacher, B.; Holm, P.S. Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agents. Cancer. Res. 2006, 66, 7195-7202.
6. Pisha, E.; Chai, H.; Lee, I.S.; Chagwedera, T.E.; Farnsworth, N.R.; Cordell, G.A.; Beecher, C.W.; Fong, H.H.; Kinghorn, A.D.; Brown, D.M. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat. Med. 1995, 1, 1046-1051.
7. Schmidt, M.L.; Kuzmanoff, K.L.; Ling-Indeck, L.; Pezzuto, J.M. Betulinic acid induces apoptosis in human neuroblastoma cell lines. Eur. J. Cancer. 1997, 33, 2007-2010.
8. Wick, W.; Grimmel, C.; Wagenknecht, B.; Dichgans, J.; Weller, M.; Betulinic acid-induced apoptosis in glioma cells: A sequential requirement for new protein synthesis, formation of reactive oxygen species, and caspase processing. J. Pharmacol. Exp. Ther. 1999, 289, 1306-1312.
9. Fulda, S.; Friesen, C.; Los, M.; Scaffidi, C.; Mier, W.; Benedict, M.; Nunez, G.; Krammer, P.H.; Peter, M.E.; Debatin, K.M. Betulinic acid triggers CD95 (APO-1/Fas)-and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer. Res. 1997, 57, 4956-4964.
10. Ji, Z. N.; Ye, W.C.; Liu, G.G.; Hsiao, W.L.; 23-Hydroxybetulinic acid-mediated apoptosis is accompanied by decreases in bcl-2 expression and telomerase activity in HL-60 Cells. Life. Sci. 2002, 72, 1-9.
11. Thurnher, D.; Turhani, D.; Pelzmann, M.; Wannemacher, B.; Knerer, B.; Formanek, M.; Wacheck, V.; Selzer, E. Betulinic acid: a new cytotoxic compound against malignant head and neck cancer cells. Head Neck 2003, 25, 732-740.
12. Kessler, J.H.; Mullauer, F.B.; de Roo, G.M.; Medema, J.P. Broad in vitro efficacy of plantderived betulinic acid against cell lines derived from the most prevalent human cancer types. Cancer Lett. 2007, 251, 132-145.
13. Zuco, V.; Supino, R.; Righetti, S.C.; Cleris, L.; Marchesi, E.; Gambacorti-Passerini, C.; Formelli, F. Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells. Cancer Lett. 2002, 175, 17-25.
14. Tan, Y.; Yu, R.; Pezzuto, J.M. Betulinic acid-induced programmed cell death in human melanoma cells involves mitogen-activated protein kinase activation. Clin. Cancer Res. 2003, 9,2866-2875.
15. Fernandes, J.; Castilho, R.O.; da Costa, M.R.; Wagner-Souza, K.; Coelho Kaplan, M.A.; Gattass, C.R.; Pentacyclic triterpenes from Chrysobalanaceae species: cytotoxicity on multidrug resistant and sensitive leukemia cell lines. Cancer Lett. 2003, 190, 165-169.
16. Jung, G.R.; Kim, K.J.; Choi, C.H.; Lee, T.B.; Han, S.I.; Han, H.K.; Lim, S.C. Effect of betulinic acid on anticancer drug-resistant colon cancer cells. Basic. Clin. Pharmacol. Toxicol. 2007, 101,277-285.
17. Fulda, S.; Debatin, K.M. Sensitization for anticancer drug-induced apoptosis by betulinic Acid. Neoplasia 2005, 7, 162-170.
18. Sawada, N.; Kataoka, K.; Kondo, K.; Arimochi, H.; Fujino, H.; Takahashi, Y.; Miyoshi, T.; Kuwahara, T.; Monden, Y.; Ohnishi, Y. Betulinic acid augments the inhibitory effects of vincristine on growth and lung metastasis of B16F10 melanoma cells in mice. Br. J. Cancer 2004, 90, 1672-1678.
19. Surowiak, P.; Drag, M.; Materna, V.; Lage, H.; Dietel, M. Betulinic acid reveal stronger cytotoxic activity toward normal melanocyte cell line (NHEM-neo) than drug-resistant and drug-sensitive melanoma cell lines (MeWo). Mol. Med. Rep.2009. (in press).
20. Chintharlapalli, S.; Papineni, S.; Ramaiah, S.K.; Safe, S. Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors. Cancer Res. 2007, 67, 2816-2823.
21. Hata, K.; Hori, K.; Takahashi, S. Differentiation-and apoptosis-inducing activities by pentacyclic triterpenes on a mouse melanoma cell line. J. Nat. Prod. 2002, 65, 645-648.
22. Kellner, U.; Hutchinson, L.; Seidel, A.; Lage, H.; Danks, M.K.; Dietel, M.; Kaufmann, S. H. Decreased drug accumulation in a mitoxantrone-resistant gastric carcinoma cell line in the absence of P-glycoprotein. Int. J. Cancer 1997, 71, 817-824.
23. Lage, H.; Dietel, M. Multiple mechanisms confer different drug-resistant phenotypes in pancreatic carcinoma cells. J. Cancer Res. Clin. Oncol. 2002, 128, 349-357.
24. Osheroff, N.; Corbett, A.H.; Robinson, M.J. Mechanism of action of topoisomerase II-targeted antineoplastic drugs. Adv. Pharmacol. 1994, 29B, 105-126.
25. Wichert, A.; Stege, A.; Midorikawa, Y.; Holm, P.S.; Lage, H. Glypican-3 is involved in cellular protection against mitoxantrone in gastric carcinoma cells. Oncogene 2004, 23, 945-955.
26. Gyorffy, B.; Surowiak, P.; Kiesslich, O.; Denkert, C.; Schafer, R.; Dietel, M.; Lage, H. Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations. Int. J. Cancer 2006, 118, 1699-1712.
27. Zhao, G.; Yan, W.; Cao, D. Simultaneous determination of betulin and betulinic acid in white birch bark using RP-HPLC. J. Pharm. Biomed. Anal. 2007, 43, 959-962.
28. Kim, D.S.H.L.; Chen, Z.D.; Nguyen, V.T.; Pezzuto, J.M.; Qiu, S.X.; Lu, Z.Z.; A concise semisynthetic approach to betulinic acid from betulin. Synth. Comm. 1997, 27, 1607-1612.
29. Karpova, M.B.; Sanmun, D.; Henter, J.I.; Smirnov, A.F.; Fadeel, B. Betulinic acid, a natural cytotoxic agent, fails to trigger apoptosis in human Burkitt's lymphoma-derived B-cell lines. Int. J. Cancer 2006, 118, 246-252.
30. Denault, J.B.; Drag, M.; Salvesen, G.S.; Alves, J.; Heidt, A.B.; Deveraux, Q.; Harris, J.L. Small molecules not direct activators of caspases. Nat. Chem. Biol. 2007, 3, 519.